

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.57849229 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 6.57849229 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 6.57849229 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 6.57849229 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.57849229 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.57849229 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.78933963 |
| 8 | macrophage activation involved in immune response (GO:0002281) | 4.66012662 |
| 9 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 4.41623102 |
| 10 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.34320757 |
| 11 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.33664373 |
| 12 | response to host immune response (GO:0052572) | 4.33664373 |
| 13 | cell adhesion mediated by integrin (GO:0033627) | 4.31769360 |
| 14 | positive regulation of interferon-alpha production (GO:0032727) | 4.29005814 |
| 15 | regulation of interferon-alpha production (GO:0032647) | 4.06030153 |
| 16 | response to peptidoglycan (GO:0032494) | 4.04288047 |
| 17 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.95854386 |
| 18 | response to host (GO:0075136) | 3.95854386 |
| 19 | response to host defenses (GO:0052200) | 3.95854386 |
| 20 | neutrophil activation involved in immune response (GO:0002283) | 3.93311406 |
| 21 | I-kappaB phosphorylation (GO:0007252) | 3.80127238 |
| 22 | glial cell migration (GO:0008347) | 3.79235482 |
| 23 | adhesion of symbiont to host cell (GO:0044650) | 3.76585890 |
| 24 | virion attachment to host cell (GO:0019062) | 3.76585890 |
| 25 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.71239559 |
| 26 | wound healing, spreading of epidermal cells (GO:0035313) | 3.70246031 |
| 27 | microglial cell activation (GO:0001774) | 3.68852372 |
| 28 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.63587123 |
| 29 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.59907905 |
| 30 | regulation of mononuclear cell migration (GO:0071675) | 3.55954079 |
| 31 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.54748155 |
| 32 | detection of molecule of bacterial origin (GO:0032490) | 3.53671222 |
| 33 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.53311618 |
| 34 | natural killer cell mediated immunity (GO:0002228) | 3.53311618 |
| 35 | response to muramyl dipeptide (GO:0032495) | 3.51649297 |
| 36 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.44066236 |
| 37 | chondrocyte proliferation (GO:0035988) | 3.42058118 |
| 38 | protein localization to endosome (GO:0036010) | 3.41770719 |
| 39 | cellular response to interferon-alpha (GO:0035457) | 3.40605668 |
| 40 | apoptotic cell clearance (GO:0043277) | 3.38633453 |
| 41 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.34532968 |
| 42 | positive regulation of heat generation (GO:0031652) | 3.34466118 |
| 43 | macrophage activation (GO:0042116) | 3.28896610 |
| 44 | regulation of cholesterol storage (GO:0010885) | 3.28438279 |
| 45 | low-density lipoprotein particle clearance (GO:0034383) | 3.27578660 |
| 46 | regulation of integrin activation (GO:0033623) | 3.26646655 |
| 47 | adhesion of symbiont to host (GO:0044406) | 3.24211556 |
| 48 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.17075456 |
| 49 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.16199071 |
| 50 | collagen catabolic process (GO:0030574) | 3.15565083 |
| 51 | positive regulation of macrophage cytokine production (GO:0060907) | 3.12408826 |
| 52 | response to interferon-alpha (GO:0035455) | 3.11160450 |
| 53 | collagen metabolic process (GO:0032963) | 3.07935252 |
| 54 | immunoglobulin mediated immune response (GO:0016064) | 3.04316996 |
| 55 | barbed-end actin filament capping (GO:0051016) | 3.02942762 |
| 56 | positive regulation of interferon-beta production (GO:0032728) | 3.00188458 |
| 57 | * substrate-dependent cell migration (GO:0006929) | 2.99826439 |
| 58 | keratan sulfate catabolic process (GO:0042340) | 2.99768274 |
| 59 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.95034187 |
| 60 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.92517868 |
| 61 | granulocyte activation (GO:0036230) | 2.92479696 |
| 62 | glycosphingolipid catabolic process (GO:0046479) | 2.89913830 |
| 63 | basement membrane organization (GO:0071711) | 2.86592732 |
| 64 | endothelium development (GO:0003158) | 2.85639731 |
| 65 | positive regulation of antigen processing and presentation (GO:0002579) | 2.84710354 |
| 66 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.83311065 |
| 67 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.83002789 |
| 68 | multicellular organismal catabolic process (GO:0044243) | 2.82729051 |
| 69 | regulation of fever generation (GO:0031620) | 2.81763756 |
| 70 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.81499070 |
| 71 | lymphangiogenesis (GO:0001946) | 2.80883813 |
| 72 | NIK/NF-kappaB signaling (GO:0038061) | 2.80569951 |
| 73 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.79204550 |
| 74 | modulation by symbiont of host cellular process (GO:0044068) | 2.78318082 |
| 75 | monocyte chemotaxis (GO:0002548) | 2.77388565 |
| 76 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.77156267 |
| 77 | collagen fibril organization (GO:0030199) | 2.76391911 |
| 78 | respiratory burst (GO:0045730) | 2.76365391 |
| 79 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.75864714 |
| 80 | extracellular matrix disassembly (GO:0022617) | 2.75574754 |
| 81 | neutrophil activation (GO:0042119) | 2.74340197 |
| 82 | regulation of macrophage cytokine production (GO:0010935) | 2.72269713 |
| 83 | type I interferon signaling pathway (GO:0060337) | 2.72125058 |
| 84 | cellular response to type I interferon (GO:0071357) | 2.72125058 |
| 85 | response to type I interferon (GO:0034340) | 2.71670224 |
| 86 | neuron remodeling (GO:0016322) | 2.69006962 |
| 87 | myeloid cell activation involved in immune response (GO:0002275) | 2.68951866 |
| 88 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.67097338 |
| 89 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.66969686 |
| 90 | endodermal cell differentiation (GO:0035987) | 2.66240186 |
| 91 | positive regulation of p38MAPK cascade (GO:1900745) | 2.65509845 |
| 92 | regulation of early endosome to late endosome transport (GO:2000641) | 2.65416809 |
| 93 | multicellular organismal metabolic process (GO:0044236) | 2.63754335 |
| 94 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.62822317 |
| 95 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.61981162 |
| 96 | * axon extension (GO:0048675) | 2.61685048 |
| 97 | regulation of vitamin metabolic process (GO:0030656) | 2.61683209 |
| 98 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.61010474 |
| 99 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.60336099 |
| 100 | regulation of axon guidance (GO:1902667) | 2.57624026 |
| 101 | positive regulation of axon extension (GO:0045773) | 2.56868725 |
| 102 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.55588499 |
| 103 | modification by symbiont of host morphology or physiology (GO:0044003) | 2.55338653 |
| 104 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.54073573 |
| 105 | negative regulation of focal adhesion assembly (GO:0051895) | 2.53286744 |
| 106 | negative regulation of cell junction assembly (GO:1901889) | 2.53286744 |
| 107 | negative regulation of adherens junction organization (GO:1903392) | 2.53286744 |
| 108 | * semaphorin-plexin signaling pathway (GO:0071526) | 2.53216289 |
| 109 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.53073032 |
| 110 | wound healing, spreading of cells (GO:0044319) | 2.52342517 |
| 111 | negative regulation of interleukin-12 production (GO:0032695) | 2.52250207 |
| 112 | glycolipid catabolic process (GO:0019377) | 2.52242752 |
| 113 | negative regulation of platelet activation (GO:0010544) | 2.52164198 |
| 114 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.51958713 |
| 115 | negative regulation of lipid storage (GO:0010888) | 2.51956366 |
| 116 | craniofacial suture morphogenesis (GO:0097094) | 2.51818573 |
| 117 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.51059900 |
| 118 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.50803626 |
| 119 | positive regulation vascular endothelial growth factor production (GO:0010575) | 2.50742801 |
| 120 | regulation of chemokine biosynthetic process (GO:0045073) | 2.50384099 |
| 121 | negative regulation of catenin import into nucleus (GO:0035414) | 2.49488932 |
| 122 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.48742111 |
| 123 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.48422975 |
| 124 | positive regulation of chemokine production (GO:0032722) | 2.47810077 |
| 125 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.47173717 |
| 126 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.46761923 |
| 127 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.46130755 |
| 128 | regulation of podosome assembly (GO:0071801) | 2.44973511 |
| 129 | regulation of antigen processing and presentation (GO:0002577) | 2.44615081 |
| 130 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 2.43840204 |
| 131 | Notch signaling involved in heart development (GO:0061314) | 2.43339276 |
| 132 | plasma membrane repair (GO:0001778) | 2.43159408 |
| 133 | positive regulation of interleukin-6 production (GO:0032755) | 2.42743322 |
| 134 | chondrocyte development (GO:0002063) | 2.42419893 |
| 135 | endothelial cell morphogenesis (GO:0001886) | 2.41426204 |
| 136 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.41349697 |
| 137 | regulation of heat generation (GO:0031650) | 2.40798639 |
| 138 | extracellular fibril organization (GO:0043206) | 2.40312209 |
| 139 | hyaluronan catabolic process (GO:0030214) | 2.39328505 |
| 140 | blood vessel maturation (GO:0001955) | 2.38716136 |
| 141 | positive regulation of leukocyte degranulation (GO:0043302) | 2.37542121 |
| 142 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.37514584 |
| 143 | decidualization (GO:0046697) | 2.37309903 |
| 144 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.37171691 |
| 145 | cellular response to virus (GO:0098586) | 2.36749382 |
| 146 | * axon extension involved in axon guidance (GO:0048846) | 2.36675843 |
| 147 | * neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.36675843 |
| 148 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.36235335 |
| 149 | epithelial cell-cell adhesion (GO:0090136) | 2.36215288 |
| 150 | stress fiber assembly (GO:0043149) | 2.35473087 |
| 151 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.35112372 |
| 152 | negative regulation of interleukin-17 production (GO:0032700) | 2.34016715 |
| 153 | positive regulation of mast cell degranulation (GO:0043306) | 2.33234992 |
| 154 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.33234992 |
| 155 | regulation of mast cell degranulation (GO:0043304) | 2.32934963 |
| 156 | positive regulation of interleukin-12 production (GO:0032735) | 2.32889591 |
| 157 | fibril organization (GO:0097435) | 2.32816846 |
| 158 | superoxide anion generation (GO:0042554) | 2.31212905 |
| 159 | glomerular visceral epithelial cell development (GO:0072015) | 2.30917116 |
| 160 | positive regulation of fat cell differentiation (GO:0045600) | 2.29351071 |
| 161 | oligosaccharide catabolic process (GO:0009313) | 2.28144277 |
| 162 | positive regulation of odontogenesis (GO:0042482) | 2.27563568 |
| 163 | endocytic recycling (GO:0032456) | 2.27503099 |
| 164 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.27484265 |
| 165 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.27258172 |
| 166 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.26871012 |
| 167 | cellular response to vitamin D (GO:0071305) | 2.26248059 |
| 168 | venous blood vessel morphogenesis (GO:0048845) | 2.25750413 |
| 169 | skin morphogenesis (GO:0043589) | 2.25269624 |
| 170 | * vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.23549122 |
| 171 | negative regulation of axon guidance (GO:1902668) | 2.22162231 |
| 172 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.21977244 |
| 173 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.21573136 |
| 174 | glomerular epithelial cell development (GO:0072310) | 2.20939812 |
| 175 | cell migration involved in heart development (GO:0060973) | 2.20744498 |
| 176 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 2.20193694 |
| 177 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.20126115 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.03518229 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.78532024 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.95827251 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.57839609 |
| 5 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.53670483 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.41537861 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.36664063 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.29958406 |
| 9 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.93079021 |
| 10 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.79543947 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.74105712 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.68687018 |
| 13 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.62582820 |
| 14 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.50666616 |
| 15 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.18830476 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.15062618 |
| 17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.14050455 |
| 18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.97980905 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.96803778 |
| 20 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.96412428 |
| 21 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.93598656 |
| 22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.93494533 |
| 23 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.90327037 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.89454768 |
| 25 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.86186110 |
| 26 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.86186110 |
| 27 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.85578320 |
| 28 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.83214051 |
| 29 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.83081750 |
| 30 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.80456826 |
| 31 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.77002760 |
| 32 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.76788132 |
| 33 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.74741853 |
| 34 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.74204562 |
| 35 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.71420419 |
| 36 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.66785387 |
| 37 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.66505831 |
| 38 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.66377439 |
| 39 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.63875860 |
| 40 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.56723467 |
| 41 | CJUN_26792858_Chip-Seq_BT549_Human | 1.56378066 |
| 42 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.55715385 |
| 43 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.54850080 |
| 44 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.51324157 |
| 45 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.50937903 |
| 46 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.50937903 |
| 47 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.49516117 |
| 48 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.47791838 |
| 49 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.46601843 |
| 50 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.46585609 |
| 51 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.43711994 |
| 52 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.43175481 |
| 53 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.40463824 |
| 54 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.39652161 |
| 55 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.38513435 |
| 56 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.36482705 |
| 57 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.35802314 |
| 58 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.35679652 |
| 59 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.35484133 |
| 60 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.34214611 |
| 61 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.33170340 |
| 62 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.31393676 |
| 63 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.30845955 |
| 64 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.29949550 |
| 65 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.28502723 |
| 66 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.27544552 |
| 67 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.25851965 |
| 68 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.24652119 |
| 69 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.24502296 |
| 70 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.23185972 |
| 71 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.23185972 |
| 72 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.20987035 |
| 73 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.19553730 |
| 74 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.17965689 |
| 75 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.17509482 |
| 76 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.16071942 |
| 77 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.15489451 |
| 78 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.14743440 |
| 79 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13590545 |
| 80 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.13573281 |
| 81 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.13257833 |
| 82 | TP53_16413492_ChIP-PET_HCT116_Human | 1.12891495 |
| 83 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.12667411 |
| 84 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.11413313 |
| 85 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.10972960 |
| 86 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.10644173 |
| 87 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.09904442 |
| 88 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.09422063 |
| 89 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.09308904 |
| 90 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.07673189 |
| 91 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.07502827 |
| 92 | RXR_22108803_ChIP-Seq_LS180_Human | 1.06549021 |
| 93 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.06062651 |
| 94 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.04167223 |
| 95 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.02395433 |
| 96 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.02365488 |
| 97 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.01889960 |
| 98 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.01889960 |
| 99 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.01597494 |
| 100 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.01131430 |
| 101 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.00822113 |
| 102 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.00606834 |
| 103 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00162897 |
| 104 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.99745765 |
| 105 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.99323355 |
| 106 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.99012398 |
| 107 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.98229854 |
| 108 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.98158378 |
| 109 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.97638110 |
| 110 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.97477289 |
| 111 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96839056 |
| 112 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.96574546 |
| 113 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.96336193 |
| 114 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95081727 |
| 115 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94517103 |
| 116 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.94145734 |
| 117 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.93722189 |
| 118 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.93484318 |
| 119 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.93477554 |
| 120 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.93318995 |
| 121 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.91074463 |
| 122 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.90783915 |
| 123 | KDM2B_26808549_Chip-Seq_K562_Human | 0.90009216 |
| 124 | MAF_26560356_Chip-Seq_TH1_Human | 0.87673879 |
| 125 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87412081 |
| 126 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.86921373 |
| 127 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.86739742 |
| 128 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.86428675 |
| 129 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.85645851 |
| 130 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.84366932 |
| 131 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.82475301 |
| 132 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.81751333 |
| 133 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.81428355 |
| 134 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.79468200 |
| 135 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.79221220 |
| 136 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.78810878 |
| 137 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.78340922 |
| 138 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.78230902 |
| 139 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.77112963 |
| 140 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.75641348 |
| 141 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75321504 |
| 142 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.75205606 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 4.39580221 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 4.31852498 |
| 3 | MP0003303_peritoneal_inflammation | 3.80506081 |
| 4 | MP0005257_abnormal_intraocular_pressure | 3.04965353 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 2.98363681 |
| 6 | MP0005058_abnormal_lysosome_morphology | 2.86402481 |
| 7 | MP0004510_myositis | 2.86024377 |
| 8 | MP0003436_decreased_susceptibility_to | 2.59982319 |
| 9 | MP0001835_abnormal_antigen_presentation | 2.45097113 |
| 10 | MP0003172_abnormal_lysosome_physiology | 2.34981211 |
| 11 | MP0005275_abnormal_skin_tensile | 2.29073361 |
| 12 | MP0002419_abnormal_innate_immunity | 2.28213311 |
| 13 | MP0006082_CNS_inflammation | 2.26375319 |
| 14 | MP0009278_abnormal_bone_marrow | 2.25932972 |
| 15 | MP0004858_abnormal_nervous_system | 2.14044785 |
| 16 | MP0002998_abnormal_bone_remodeling | 2.12106517 |
| 17 | MP0010030_abnormal_orbit_morphology | 2.11638206 |
| 18 | MP0001958_emphysema | 2.06058927 |
| 19 | MP0001533_abnormal_skeleton_physiology | 2.05434106 |
| 20 | MP0009785_altered_susceptibility_to | 2.04033915 |
| 21 | MP0003091_abnormal_cell_migration | 1.98235342 |
| 22 | MP0003566_abnormal_cell_adhesion | 1.96546166 |
| 23 | MP0003448_altered_tumor_morphology | 1.94782524 |
| 24 | MP0005076_abnormal_cell_differentiation | 1.90505721 |
| 25 | MP0002877_abnormal_melanocyte_morpholog | 1.89471841 |
| 26 | MP0005000_abnormal_immune_tolerance | 1.84585866 |
| 27 | MP0002148_abnormal_hypersensitivity_rea | 1.82619843 |
| 28 | MP0003300_gastrointestinal_ulcer | 1.81749811 |
| 29 | MP0001849_ear_inflammation | 1.81203112 |
| 30 | MP0003279_aneurysm | 1.81151192 |
| 31 | MP0005595_abnormal_vascular_smooth | 1.80922064 |
| 32 | MP0005503_abnormal_tendon_morphology | 1.80432418 |
| 33 | MP0005167_abnormal_blood-brain_barrier | 1.77712745 |
| 34 | MP0003941_abnormal_skin_development | 1.75596694 |
| 35 | MP0003724_increased_susceptibility_to | 1.71345222 |
| 36 | MP0001790_abnormal_immune_system | 1.67703300 |
| 37 | MP0005387_immune_system_phenotype | 1.67703300 |
| 38 | * MP0001879_abnormal_lymphatic_vessel | 1.67384205 |
| 39 | MP0008004_abnormal_stomach_pH | 1.67134941 |
| 40 | MP0005025_abnormal_response_to | 1.64917072 |
| 41 | MP0002452_abnormal_antigen_presenting | 1.64602549 |
| 42 | MP0004947_skin_inflammation | 1.64101149 |
| 43 | MP0003329_amyloid_beta_deposits | 1.54670323 |
| 44 | MP0005248_abnormal_Harderian_gland | 1.53364038 |
| 45 | MP0000604_amyloidosis | 1.53192794 |
| 46 | MP0004272_abnormal_basement_membrane | 1.52218736 |
| 47 | MP0000343_altered_response_to | 1.51419120 |
| 48 | MP0000767_abnormal_smooth_muscle | 1.48253924 |
| 49 | MP0010307_abnormal_tumor_latency | 1.45190320 |
| 50 | MP0005390_skeleton_phenotype | 1.41294624 |
| 51 | MP0003950_abnormal_plasma_membrane | 1.40632772 |
| 52 | MP0000685_abnormal_immune_system | 1.38599676 |
| 53 | MP0000733_abnormal_muscle_development | 1.35279193 |
| 54 | MP0002723_abnormal_immune_serum | 1.30095155 |
| 55 | MP0003075_altered_response_to | 1.28760618 |
| 56 | MP0003634_abnormal_glial_cell | 1.28355948 |
| 57 | MP0001800_abnormal_humoral_immune | 1.25145292 |
| 58 | MP0003385_abnormal_body_wall | 1.24375586 |
| 59 | MP0003828_pulmonary_edema | 1.24125238 |
| 60 | MP0010352_gastrointestinal_tract_polyps | 1.23152301 |
| 61 | MP0002254_reproductive_system_inflammat | 1.22751204 |
| 62 | MP0005023_abnormal_wound_healing | 1.21485467 |
| 63 | MP0005464_abnormal_platelet_physiology | 1.19863595 |
| 64 | MP0005164_abnormal_response_to | 1.14919775 |
| 65 | MP0001819_abnormal_immune_cell | 1.14324931 |
| 66 | MP0009764_decreased_sensitivity_to | 1.11029472 |
| 67 | MP0002139_abnormal_hepatobiliary_system | 1.09253795 |
| 68 | MP0002420_abnormal_adaptive_immunity | 1.09220168 |
| 69 | MP0000534_abnormal_ureter_morphology | 1.09004537 |
| 70 | MP0005197_abnormal_uvea_morphology | 1.08913324 |
| 71 | MP0000371_diluted_coat_color | 1.07369579 |
| 72 | MP0004185_abnormal_adipocyte_glucose | 1.06092599 |
| 73 | MP0003045_fibrosis | 1.04320883 |
| 74 | MP0001542_abnormal_bone_strength | 1.04129590 |
| 75 | MP0005171_absent_coat_pigmentation | 1.04059649 |
| 76 | MP0005623_abnormal_meninges_morphology | 1.03551228 |
| 77 | MP0002896_abnormal_bone_mineralization | 1.02701772 |
| 78 | MP0001545_abnormal_hematopoietic_system | 1.02021614 |
| 79 | MP0005397_hematopoietic_system_phenotyp | 1.02021614 |
| 80 | MP0002405_respiratory_system_inflammati | 1.01684933 |
| 81 | MP0000858_altered_metastatic_potential | 1.01134038 |
| 82 | MP0002006_tumorigenesis | 1.00249240 |
| 83 | MP0009250_abnormal_appendicular_skeleto | 0.99850183 |
| 84 | MP0009840_abnormal_foam_cell | 0.99529222 |
| 85 | MP0003795_abnormal_bone_structure | 0.99469497 |
| 86 | MP0002332_abnormal_exercise_endurance | 0.97184306 |
| 87 | MP0005409_darkened_coat_color | 0.96723850 |
| 88 | MP0002933_joint_inflammation | 0.95923692 |
| 89 | MP0001614_abnormal_blood_vessel | 0.95370555 |
| 90 | MP0002295_abnormal_pulmonary_circulatio | 0.95114286 |
| 91 | MP0005165_increased_susceptibility_to | 0.94724684 |
| 92 | MP0005166_decreased_susceptibility_to | 0.94622426 |
| 93 | MP0001845_abnormal_inflammatory_respons | 0.93798212 |
| 94 | MP0003690_abnormal_glial_cell | 0.93781790 |
| 95 | MP0005193_abnormal_anterior_eye | 0.91305743 |
| 96 | MP0005174_abnormal_tail_pigmentation | 0.89826217 |
| 97 | MP0010368_abnormal_lymphatic_system | 0.89778919 |
| 98 | MP0000163_abnormal_cartilage_morphology | 0.89323272 |
| 99 | MP0000428_abnormal_craniofacial_morphol | 0.89107685 |
| 100 | MP0003136_yellow_coat_color | 0.89046103 |
| 101 | MP0005508_abnormal_skeleton_morphology | 0.87435190 |
| 102 | MP0000920_abnormal_myelination | 0.87260683 |
| 103 | MP0008469_abnormal_protein_level | 0.86361778 |
| 104 | MP0002166_altered_tumor_susceptibility | 0.83579419 |
| 105 | MP0000249_abnormal_blood_vessel | 0.83228673 |
| 106 | MP0000537_abnormal_urethra_morphology | 0.82851608 |
| 107 | MP0006054_spinal_hemorrhage | 0.82544443 |
| 108 | MP0003453_abnormal_keratinocyte_physiol | 0.82362150 |
| 109 | MP0001243_abnormal_dermal_layer | 0.81591968 |
| 110 | MP0009053_abnormal_anal_canal | 0.81071500 |
| 111 | MP0001915_intracranial_hemorrhage | 0.80458678 |
| 112 | MP0009384_cardiac_valve_regurgitation | 0.80205719 |
| 113 | MP0002115_abnormal_skeleton_extremities | 0.80014586 |
| 114 | MP0001851_eye_inflammation | 0.78335787 |
| 115 | MP0000015_abnormal_ear_pigmentation | 0.77713794 |
| 116 | MP0000432_abnormal_head_morphology | 0.77688249 |
| 117 | MP0002925_abnormal_cardiovascular_devel | 0.77336205 |
| 118 | MP0003191_abnormal_cellular_cholesterol | 0.77244150 |
| 119 | MP0002113_abnormal_skeleton_development | 0.76265641 |
| 120 | MP0005671_abnormal_response_to | 0.75485415 |
| 121 | MP0000049_abnormal_middle_ear | 0.74949952 |
| 122 | MP0002168_other_aberrant_phenotype | 0.74431723 |
| 123 | MP0003755_abnormal_palate_morphology | 0.73875453 |
| 124 | MP0001299_abnormal_eye_distance/ | 0.73458241 |
| 125 | MP0010155_abnormal_intestine_physiology | 0.72673094 |
| 126 | MP0004130_abnormal_muscle_cell | 0.72448038 |
| 127 | MP0002092_abnormal_eye_morphology | 0.72278576 |
| 128 | MP0003935_abnormal_craniofacial_develop | 0.72107853 |
| 129 | MP0002277_abnormal_respiratory_mucosa | 0.69163498 |
| 130 | MP0002060_abnormal_skin_morphology | 0.67618972 |
| 131 | MP0000516_abnormal_urinary_system | 0.67337108 |
| 132 | MP0005367_renal/urinary_system_phenotyp | 0.67337108 |
| 133 | MP0003942_abnormal_urinary_system | 0.65596444 |
| 134 | MP0002116_abnormal_craniofacial_bone | 0.64954669 |
| 135 | MP0002932_abnormal_joint_morphology | 0.63383170 |
| 136 | MP0002697_abnormal_eye_size | 0.59904787 |
| 137 | * MP0000778_abnormal_nervous_system | 0.59594482 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.56740797 |
| 2 | Neurofibrillary tangles (HP:0002185) | 4.31524851 |
| 3 | Nuclear cataract (HP:0100018) | 4.26175912 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.18665219 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 4.17904319 |
| 6 | Premature rupture of membranes (HP:0001788) | 3.95959836 |
| 7 | Increased cerebral lipofuscin (HP:0011813) | 3.87720118 |
| 8 | Protrusio acetabuli (HP:0003179) | 3.81096950 |
| 9 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.62042787 |
| 10 | Peritonitis (HP:0002586) | 3.51160882 |
| 11 | Arterial tortuosity (HP:0005116) | 3.41352978 |
| 12 | Abnormality of macrophages (HP:0004311) | 3.31757493 |
| 13 | Vascular tortuosity (HP:0004948) | 3.25765728 |
| 14 | Cerebral inclusion bodies (HP:0100314) | 3.13953380 |
| 15 | Hematochezia (HP:0002573) | 3.09600232 |
| 16 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.05101553 |
| 17 | Mediastinal lymphadenopathy (HP:0100721) | 3.03608672 |
| 18 | Cerebral aneurysm (HP:0004944) | 3.02783296 |
| 19 | Disinhibition (HP:0000734) | 3.01756522 |
| 20 | Vertebral compression fractures (HP:0002953) | 2.98018654 |
| 21 | Gingivitis (HP:0000230) | 2.94111742 |
| 22 | Thick nail (HP:0001805) | 2.88948583 |
| 23 | Myocardial infarction (HP:0001658) | 2.83542240 |
| 24 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.77207112 |
| 25 | Osteolytic defects of the hand bones (HP:0009699) | 2.77207112 |
| 26 | Shallow orbits (HP:0000586) | 2.72255153 |
| 27 | Aortic dissection (HP:0002647) | 2.69339802 |
| 28 | Prostate neoplasm (HP:0100787) | 2.68728070 |
| 29 | Autoimmune thrombocytopenia (HP:0001973) | 2.65991888 |
| 30 | Vacuolated lymphocytes (HP:0001922) | 2.64039237 |
| 31 | Spondylolisthesis (HP:0003302) | 2.62969480 |
| 32 | Ankle contracture (HP:0006466) | 2.62434675 |
| 33 | Axonal loss (HP:0003447) | 2.61963373 |
| 34 | Orchitis (HP:0100796) | 2.58020126 |
| 35 | Tetraparesis (HP:0002273) | 2.52705143 |
| 36 | Cervical subluxation (HP:0003308) | 2.48892617 |
| 37 | Periodontitis (HP:0000704) | 2.45340982 |
| 38 | Overgrowth (HP:0001548) | 2.45245847 |
| 39 | Follicular hyperkeratosis (HP:0007502) | 2.43424609 |
| 40 | Absent frontal sinuses (HP:0002688) | 2.43209098 |
| 41 | Spinal rigidity (HP:0003306) | 2.42744441 |
| 42 | Ulnar bowing (HP:0003031) | 2.42256212 |
| 43 | Dilatation of the ascending aorta (HP:0005111) | 2.41207057 |
| 44 | Diminished motivation (HP:0000745) | 2.39292637 |
| 45 | Abnormality of glycolipid metabolism (HP:0010969) | 2.36565942 |
| 46 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.36565942 |
| 47 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.36565942 |
| 48 | Mitral valve prolapse (HP:0001634) | 2.34546950 |
| 49 | Atrophic scars (HP:0001075) | 2.28325700 |
| 50 | Spinal cord lesions (HP:0100561) | 2.28071608 |
| 51 | Syringomyelia (HP:0003396) | 2.28071608 |
| 52 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.26350282 |
| 53 | Myositis (HP:0100614) | 2.25567761 |
| 54 | Broad metatarsal (HP:0001783) | 2.24606997 |
| 55 | Systemic lupus erythematosus (HP:0002725) | 2.24333648 |
| 56 | Recurrent skin infections (HP:0001581) | 2.22712928 |
| 57 | Premature loss of primary teeth (HP:0006323) | 2.22447550 |
| 58 | Genu recurvatum (HP:0002816) | 2.22222559 |
| 59 | Soft skin (HP:0000977) | 2.21086035 |
| 60 | Optic neuritis (HP:0100653) | 2.20107221 |
| 61 | Retrobulbar optic neuritis (HP:0100654) | 2.20107221 |
| 62 | Abnormality of dentin (HP:0010299) | 2.17536366 |
| 63 | Dysostosis multiplex (HP:0000943) | 2.16754683 |
| 64 | Mutism (HP:0002300) | 2.16603161 |
| 65 | Bladder diverticulum (HP:0000015) | 2.15816488 |
| 66 | Bone pain (HP:0002653) | 2.15037048 |
| 67 | Aortic aneurysm (HP:0004942) | 2.14730720 |
| 68 | Stomatitis (HP:0010280) | 2.14637530 |
| 69 | Basal ganglia calcification (HP:0002135) | 2.13897265 |
| 70 | Porencephaly (HP:0002132) | 2.13488720 |
| 71 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.10918436 |
| 72 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.06320075 |
| 73 | Frequent falls (HP:0002359) | 2.05553128 |
| 74 | Hypoplasia of the iris (HP:0007676) | 2.04743809 |
| 75 | Increased connective tissue (HP:0009025) | 2.04537805 |
| 76 | Wrist flexion contracture (HP:0001239) | 2.02753713 |
| 77 | Pathologic fracture (HP:0002756) | 2.00325305 |
| 78 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.99813271 |
| 79 | Interstitial pulmonary disease (HP:0006530) | 1.98969750 |
| 80 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.97525953 |
| 81 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.97525953 |
| 82 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.97525953 |
| 83 | Zonular cataract (HP:0010920) | 1.97450910 |
| 84 | Wormian bones (HP:0002645) | 1.94832619 |
| 85 | Mucopolysacchariduria (HP:0008155) | 1.94645807 |
| 86 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.94645807 |
| 87 | Radial bowing (HP:0002986) | 1.93842990 |
| 88 | Abnormality of the peritoneum (HP:0002585) | 1.92947504 |
| 89 | Obstructive lung disease (HP:0006536) | 1.92876033 |
| 90 | Chronic obstructive pulmonary disease (HP:0006510) | 1.92876033 |
| 91 | Blue sclerae (HP:0000592) | 1.92659448 |
| 92 | Fragile skin (HP:0001030) | 1.91287116 |
| 93 | Increased density of long bones (HP:0006392) | 1.90965524 |
| 94 | Short 4th metacarpal (HP:0010044) | 1.90337983 |
| 95 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.90337983 |
| 96 | Thin bony cortex (HP:0002753) | 1.88741615 |
| 97 | Esophageal varix (HP:0002040) | 1.86541813 |
| 98 | Alopecia of scalp (HP:0002293) | 1.86344855 |
| 99 | Arterial thrombosis (HP:0004420) | 1.86164293 |
| 100 | Biconcave vertebral bodies (HP:0004586) | 1.86145285 |
| 101 | Pulmonary artery stenosis (HP:0004415) | 1.86061008 |
| 102 | Abnormality of the frontal sinuses (HP:0002687) | 1.85226477 |
| 103 | Supranuclear gaze palsy (HP:0000605) | 1.83337163 |
| 104 | Cortical dysplasia (HP:0002539) | 1.82698892 |
| 105 | Turricephaly (HP:0000262) | 1.81812830 |
| 106 | Long toe (HP:0010511) | 1.81760863 |
| 107 | Ulnar claw (HP:0001178) | 1.81423016 |
| 108 | Joint stiffness (HP:0001387) | 1.81331511 |
| 109 | Femoral bowing (HP:0002980) | 1.81308744 |
| 110 | Ectopia lentis (HP:0001083) | 1.80845139 |
| 111 | Protuberant abdomen (HP:0001538) | 1.80412684 |
| 112 | Tibial bowing (HP:0002982) | 1.78773219 |
| 113 | Subacute progressive viral hepatitis (HP:0006572) | 1.76819321 |
| 114 | Cellulitis (HP:0100658) | 1.76483866 |
| 115 | Asymmetric septal hypertrophy (HP:0001670) | 1.76026654 |
| 116 | Loss of speech (HP:0002371) | 1.75737581 |
| 117 | Persistence of primary teeth (HP:0006335) | 1.75663678 |
| 118 | Natal tooth (HP:0000695) | 1.75496325 |
| 119 | Recurrent fungal infections (HP:0002841) | 1.75389457 |
| 120 | Short nail (HP:0001799) | 1.75236167 |
| 121 | Distal upper limb amyotrophy (HP:0007149) | 1.75161746 |
| 122 | Upper limb amyotrophy (HP:0009129) | 1.75161746 |
| 123 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.74757405 |
| 124 | Aneurysm (HP:0002617) | 1.74455657 |
| 125 | Hypoventilation (HP:0002791) | 1.74072563 |
| 126 | Glomerulonephritis (HP:0000099) | 1.73651258 |
| 127 | Inappropriate behavior (HP:0000719) | 1.72468846 |
| 128 | Hyperacusis (HP:0010780) | 1.72048915 |
| 129 | Hammertoe (HP:0001765) | 1.71897657 |
| 130 | Ovoid vertebral bodies (HP:0003300) | 1.71466154 |
| 131 | Vasculitis (HP:0002633) | 1.71024885 |
| 132 | Thoracolumbar scoliosis (HP:0002944) | 1.70919123 |
| 133 | Apathy (HP:0000741) | 1.70029505 |
| 134 | Nephritis (HP:0000123) | 1.67485959 |
| 135 | Hyperextensible skin (HP:0000974) | 1.67463336 |
| 136 | Hand muscle atrophy (HP:0009130) | 1.65955640 |
| 137 | Coxa vara (HP:0002812) | 1.65488256 |
| 138 | Neonatal short-limb short stature (HP:0008921) | 1.62430581 |
| 139 | Cupped ribs (HP:0000887) | 1.62396997 |
| 140 | Aortic regurgitation (HP:0001659) | 1.61794370 |
| 141 | Conjunctival telangiectasia (HP:0000524) | 1.61274487 |
| 142 | Osteopenia (HP:0000938) | 1.61120075 |
| 143 | Metaphyseal irregularity (HP:0003025) | 1.59786858 |
| 144 | White forelock (HP:0002211) | 1.59205319 |
| 145 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.58516891 |
| 146 | Skull defect (HP:0001362) | 1.57178246 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 3.45859512 |
| 2 | TTN | 3.16765921 |
| 3 | TBK1 | 2.93392220 |
| 4 | RIPK4 | 2.90749017 |
| 5 | DDR2 | 2.63367786 |
| 6 | TYK2 | 2.56599172 |
| 7 | RIPK1 | 2.40452950 |
| 8 | NTRK1 | 2.37307774 |
| 9 | KIT | 2.24939714 |
| 10 | JAK1 | 2.23141018 |
| 11 | GRK7 | 2.21991950 |
| 12 | TRIB3 | 2.04038198 |
| 13 | SIK1 | 2.00067456 |
| 14 | ERBB4 | 1.95695376 |
| 15 | TYRO3 | 1.94526044 |
| 16 | IKBKE | 1.92087003 |
| 17 | NME2 | 1.89956498 |
| 18 | ERN1 | 1.87067730 |
| 19 | BLK | 1.81150814 |
| 20 | SIK2 | 1.81085912 |
| 21 | JAK3 | 1.79650748 |
| 22 | IKBKB | 1.77665478 |
| 23 | IRAK3 | 1.75528110 |
| 24 | MAP3K13 | 1.69575728 |
| 25 | CAMK1D | 1.68437420 |
| 26 | PKN2 | 1.67985059 |
| 27 | BMX | 1.67280923 |
| 28 | IRAK4 | 1.67223507 |
| 29 | PDGFRA | 1.66131809 |
| 30 | LATS1 | 1.65490139 |
| 31 | TGFBR2 | 1.61239034 |
| 32 | PTK6 | 1.56032005 |
| 33 | PBK | 1.56030159 |
| 34 | CHUK | 1.51541409 |
| 35 | MARK1 | 1.49123155 |
| 36 | FGR | 1.48788494 |
| 37 | MET | 1.43802844 |
| 38 | CDC42BPA | 1.39697158 |
| 39 | CSF1R | 1.35230241 |
| 40 | NEK9 | 1.33915881 |
| 41 | MAP3K3 | 1.28810104 |
| 42 | CAMK1G | 1.27917733 |
| 43 | LIMK1 | 1.25930219 |
| 44 | EPHB2 | 1.25324680 |
| 45 | RPS6KA4 | 1.24297681 |
| 46 | CSK | 1.22895770 |
| 47 | TGFBR1 | 1.22439642 |
| 48 | CDK12 | 1.21574881 |
| 49 | MAP3K10 | 1.20082437 |
| 50 | HCK | 1.14239275 |
| 51 | STK3 | 1.10087583 |
| 52 | EPHA3 | 1.07488814 |
| 53 | DMPK | 1.06292301 |
| 54 | PDGFRB | 1.04538007 |
| 55 | TESK1 | 1.01715437 |
| 56 | CASK | 0.97506354 |
| 57 | MARK3 | 0.97174090 |
| 58 | FGFR3 | 0.96181833 |
| 59 | KDR | 0.93789462 |
| 60 | ERBB3 | 0.92197969 |
| 61 | CDK6 | 0.90963697 |
| 62 | LMTK2 | 0.89525489 |
| 63 | EGFR | 0.88890099 |
| 64 | EIF2AK2 | 0.86958396 |
| 65 | TAOK2 | 0.83877495 |
| 66 | PAK4 | 0.82045430 |
| 67 | JAK2 | 0.81326554 |
| 68 | TRPM7 | 0.81251848 |
| 69 | ROCK2 | 0.80776025 |
| 70 | EPHA2 | 0.80183444 |
| 71 | ABL2 | 0.80129154 |
| 72 | PIM2 | 0.79985430 |
| 73 | MAP3K11 | 0.75749846 |
| 74 | PLK2 | 0.75018233 |
| 75 | EPHB1 | 0.72917726 |
| 76 | MAP3K6 | 0.70935308 |
| 77 | PAK2 | 0.69342121 |
| 78 | ABL1 | 0.68978871 |
| 79 | MAP3K5 | 0.66138117 |
| 80 | MYLK | 0.65695655 |
| 81 | TIE1 | 0.65343726 |
| 82 | PTK2 | 0.65249007 |
| 83 | PTK2B | 0.63466036 |
| 84 | KSR1 | 0.63085563 |
| 85 | CLK1 | 0.61659847 |
| 86 | ADRBK2 | 0.61011072 |
| 87 | PRKD3 | 0.60925572 |
| 88 | ACVR1B | 0.60659732 |
| 89 | LCK | 0.60420091 |
| 90 | MTOR | 0.59237255 |
| 91 | FES | 0.58708803 |
| 92 | FYN | 0.58110137 |
| 93 | PKN1 | 0.56867923 |
| 94 | FLT3 | 0.56232432 |
| 95 | NTRK2 | 0.56211232 |
| 96 | LYN | 0.56092962 |
| 97 | LATS2 | 0.56040966 |
| 98 | FGFR4 | 0.55969527 |
| 99 | DAPK2 | 0.55823374 |
| 100 | INSR | 0.55067056 |
| 101 | MARK2 | 0.54549119 |
| 102 | MOS | 0.54238988 |
| 103 | SRC | 0.52599143 |
| 104 | MATK | 0.50295050 |
| 105 | SIK3 | 0.49845978 |
| 106 | STK10 | 0.49814978 |
| 107 | SCYL2 | 0.49812127 |
| 108 | GSK3A | 0.49540420 |
| 109 | PAK6 | 0.49462012 |
| 110 | DAPK3 | 0.49069887 |
| 111 | DYRK1B | 0.46986268 |
| 112 | LRRK2 | 0.46462864 |
| 113 | PRKD2 | 0.45827207 |
| 114 | MAPK7 | 0.44929034 |
| 115 | MST1R | 0.44677655 |
| 116 | ERBB2 | 0.44411600 |
| 117 | IGF1R | 0.43221971 |
| 118 | CDK15 | 0.40518968 |
| 119 | PIM1 | 0.40517736 |
| 120 | FER | 0.40406798 |
| 121 | RPS6KA2 | 0.39770272 |
| 122 | NUAK1 | 0.39742860 |
| 123 | RET | 0.39260506 |
| 124 | SYK | 0.39213310 |
| 125 | ALK | 0.39180843 |
| 126 | CDK14 | 0.38877106 |
| 127 | CDK18 | 0.38747109 |
| 128 | STK4 | 0.38744489 |
| 129 | TAOK3 | 0.37906444 |
| 130 | STK38L | 0.37716993 |
| 131 | ICK | 0.36396506 |
| 132 | TNIK | 0.35934376 |
| 133 | PRKCH | 0.35877363 |
| 134 | SGK1 | 0.35726996 |
| 135 | PRKCD | 0.34903891 |
| 136 | KSR2 | 0.34746382 |
| 137 | ROCK1 | 0.34727388 |
| 138 | ARAF | 0.32669354 |
| 139 | MAP3K9 | 0.31791367 |
| 140 | ZAP70 | 0.31662559 |
| 141 | CDK11A | 0.31179811 |
| 142 | TAOK1 | 0.31121392 |
| 143 | CSNK1A1L | 0.29567143 |
| 144 | EEF2K | 0.27589069 |
| 145 | CDK5 | 0.27096778 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.70106112 |
| 2 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.48780622 |
| 3 | Malaria_Homo sapiens_hsa05144 | 2.30077566 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.25791157 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.17503390 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.00878583 |
| 7 | Tuberculosis_Homo sapiens_hsa05152 | 1.99156502 |
| 8 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.97475549 |
| 9 | Pertussis_Homo sapiens_hsa05133 | 1.84681983 |
| 10 | Lysosome_Homo sapiens_hsa04142 | 1.78677027 |
| 11 | Phagosome_Homo sapiens_hsa04145 | 1.77302013 |
| 12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.77045400 |
| 13 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.65753254 |
| 14 | Legionellosis_Homo sapiens_hsa05134 | 1.65646066 |
| 15 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.60472405 |
| 16 | Measles_Homo sapiens_hsa05162 | 1.56019201 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.54701529 |
| 18 | Influenza A_Homo sapiens_hsa05164 | 1.52159631 |
| 19 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.51870251 |
| 20 | Salmonella infection_Homo sapiens_hsa05132 | 1.50308207 |
| 21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.50229854 |
| 22 | Amoebiasis_Homo sapiens_hsa05146 | 1.49765126 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.46707602 |
| 24 | Bladder cancer_Homo sapiens_hsa05219 | 1.42711214 |
| 25 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.42315121 |
| 26 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.40271199 |
| 27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.39096695 |
| 28 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.37540497 |
| 29 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.36287176 |
| 30 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.36045027 |
| 31 | Apoptosis_Homo sapiens_hsa04210 | 1.35378468 |
| 32 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.31129219 |
| 33 | Viral myocarditis_Homo sapiens_hsa05416 | 1.30704865 |
| 34 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.27558234 |
| 35 | Focal adhesion_Homo sapiens_hsa04510 | 1.27247010 |
| 36 | Shigellosis_Homo sapiens_hsa05131 | 1.26523730 |
| 37 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.23993936 |
| 38 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.20947697 |
| 39 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.19645885 |
| 40 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.12447721 |
| 41 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.11270404 |
| 42 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.10646713 |
| 43 | Hepatitis C_Homo sapiens_hsa05160 | 1.10456705 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 1.09834170 |
| 45 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.04539657 |
| 46 | Allograft rejection_Homo sapiens_hsa05330 | 1.04424515 |
| 47 | Asthma_Homo sapiens_hsa05310 | 1.00901367 |
| 48 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.99822769 |
| 49 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.99446013 |
| 50 | Adherens junction_Homo sapiens_hsa04520 | 0.96356320 |
| 51 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.95391524 |
| 52 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.94396118 |
| 53 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.93163997 |
| 54 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.92993247 |
| 55 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.92976262 |
| 56 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.92183758 |
| 57 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.91434804 |
| 58 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.89915431 |
| 59 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.89613536 |
| 60 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.89480452 |
| 61 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.85742409 |
| 62 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.85321696 |
| 63 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.82477421 |
| 64 | Platelet activation_Homo sapiens_hsa04611 | 0.82156867 |
| 65 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.81547931 |
| 66 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.81203699 |
| 67 | Glioma_Homo sapiens_hsa05214 | 0.80281730 |
| 68 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.79661782 |
| 69 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.79303663 |
| 70 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.79127227 |
| 71 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.78119802 |
| 72 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.77508024 |
| 73 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.76670787 |
| 74 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.75778168 |
| 75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.74821493 |
| 76 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.74484434 |
| 77 | Melanoma_Homo sapiens_hsa05218 | 0.73501022 |
| 78 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.73378531 |
| 79 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.73310343 |
| 80 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.72642412 |
| 81 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.71837474 |
| 82 | Other glycan degradation_Homo sapiens_hsa00511 | 0.71228609 |
| 83 | Insulin resistance_Homo sapiens_hsa04931 | 0.71128966 |
| 84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.69856341 |
| 85 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.69051189 |
| 86 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.68105494 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67270353 |
| 88 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.66521031 |
| 89 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.66038694 |
| 90 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.65684238 |
| 91 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.64425206 |
| 92 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.63923911 |
| 93 | Gap junction_Homo sapiens_hsa04540 | 0.63426739 |
| 94 | Prostate cancer_Homo sapiens_hsa05215 | 0.62445094 |
| 95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.60397113 |
| 96 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.59449697 |
| 97 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.58937901 |
| 98 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.58733200 |
| 99 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.57728963 |
| 100 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.57620447 |
| 101 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.57543738 |
| 102 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.55996092 |
| 103 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.55125782 |
| 104 | Endocytosis_Homo sapiens_hsa04144 | 0.55125512 |
| 105 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.54580169 |
| 106 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53892290 |
| 107 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.53076806 |
| 108 | Tight junction_Homo sapiens_hsa04530 | 0.52713183 |
| 109 | Axon guidance_Homo sapiens_hsa04360 | 0.52353411 |
| 110 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.52247829 |
| 111 | Melanogenesis_Homo sapiens_hsa04916 | 0.52083695 |
| 112 | HTLV-I infection_Homo sapiens_hsa05166 | 0.51973246 |
| 113 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.51635904 |
| 114 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.51565250 |
| 115 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.51292140 |
| 116 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.50633002 |
| 117 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.49707633 |
| 118 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.49657835 |
| 119 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.49546357 |
| 120 | Prion diseases_Homo sapiens_hsa05020 | 0.48921856 |
| 121 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.48192572 |
| 122 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47667904 |
| 123 | Colorectal cancer_Homo sapiens_hsa05210 | 0.47007238 |
| 124 | Galactose metabolism_Homo sapiens_hsa00052 | 0.46857793 |
| 125 | Pathways in cancer_Homo sapiens_hsa05200 | 0.46442419 |
| 126 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.45156465 |

